Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dose Response Curve: Conventional Versus Nonmonotonic01:21

Dose Response Curve: Conventional Versus Nonmonotonic

The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response relationships...
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model01:29

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The economics of decision-making in dementia care and related life-limiting illness: a narrative review.

Health economics review·2026
Same author

Antibiotic resistance, drug prices, and entry.

Economics and human biology·2026
Same author

Changing preferences: An experiment and estimation of market-incentive effects on altruism.

Journal of health economics·2023
Same author

Technology adoption by primary care physicians.

Health economics·2021
Same author

Thinking about and deciding to be an organ donor: An experimental analysis.

Social science & medicine (1982)·2020
Same author

Immunoglobulins G modulate endothelial function and affect insulin sensitivity in humans.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2020

Related Experiment Video

Updated: May 28, 2026

Measuring Delay Discounting in Humans Using an Adjusting Amount Task
07:47

Measuring Delay Discounting in Humans Using an Adjusting Amount Task

Published on: January 9, 2016

Optimal public rationing and price response.

Simona Grassi1, Ching-To Albert Ma

  • 1Faculty of Business and Economics, Department of Economics and Econometrics and Institut d'Economie et de Management de la Santé, University of Lausanne, Building Internef, CH-1015 Lausanne, Switzerland. Simona.Grassi@unil.ch

Journal of Health Economics
|October 7, 2011
PubMed
Summary

Public health care rationing strategies impact private market prices. Cost-effectiveness rationing, considering illness severity, yields better consumer surplus than wealth-based means testing.

More Related Videos

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
09:03

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

Published on: March 10, 2020

Studying Food Reward and Motivation in Humans
12:09

Studying Food Reward and Motivation in Humans

Published on: March 19, 2014

Related Experiment Videos

Last Updated: May 28, 2026

Measuring Delay Discounting in Humans Using an Adjusting Amount Task
07:47

Measuring Delay Discounting in Humans Using an Adjusting Amount Task

Published on: January 9, 2016

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
09:03

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

Published on: March 10, 2020

Studying Food Reward and Motivation in Humans
12:09

Studying Food Reward and Motivation in Humans

Published on: March 19, 2014

Area of Science:

  • Health Economics
  • Public Health Policy
  • Market Analysis

Background:

  • Limited public health budgets necessitate rationing.
  • Consumers vary in wealth and healthcare needs (treatment costs).
  • Rationed individuals may access a private market with a monopolist.

Purpose of the Study:

  • To analyze optimal public health care rationing methods.
  • To examine private sector price responses under different rationing regimes.
  • To compare consumer surplus under wealth-based versus cost-based rationing.

Main Methods:

  • Economic modeling of a public health care supplier and a private market monopolist.
  • Analysis of two distinct information regimes for rationing: means testing (wealth-based) and cost-effectiveness (cost-based).
  • Equilibrium analysis to determine rationing outcomes and price responses.

Main Results:

  • Under wealth-based rationing, both rich and poor consumers are rationed, leading to private market price reductions.
  • Cost-effectiveness rationing (threshold based on treatment cost) results in higher equilibrium consumer surplus.
  • The study identifies specific conditions for optimal rationing and price responses.

Conclusions:

  • Rationing healthcare based on cost-effectiveness is superior to wealth-based rationing in maximizing consumer welfare.
  • Public health rationing policies significantly influence private market dynamics and consumer outcomes.
  • Policy design should carefully consider information regimes to optimize resource allocation and consumer benefits.